Company Profile

Illumina Inc
Profile last edited on: 2/19/2022            CAGE: 1WCS2

Tools for large-scale analysis of genetic variation and function.
Year Founded
1998
1st Awd Year
1999
Latest Award
2006
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5200 Illumina Way
San Diego, CA 92122
   (858) 202-4500
   info@illumina.com
   www.illumina.com
Multiple Locations:   
Congressional District:   52
County:   San Diego

Public Profile

Illumina, Inc. (Illumina) was fairly extensively involved in SBIR from very soon after being founded in 1998 untill the firm outgrew size requirements by about 2006. However, the firm has maintained strong connections with younger, smaller firms on interest - several being SBIR-involved - establishing various types of working relationship and, in a few cases, acquiring the smaller player. Originally anchored in having secured exclusive worldwide rights to 13 patents and patent applications from Tufts University that were filed by one of the company's directors, Illumina develops and manufactures life science tools and integrated systems for the analysis of genetic variation and function. Organized in two business segments, the Life Sciences and Diagnostics business unit includes all products and services related to the research market, namely the product lines based on its sequencing, BeadArray, VeraCode, and real-time PCR technologies. The firm's Diagnostics business unit focuses on molecular diagnostics. Customers include genomic research centers, academic institutions, government laboratories, and clinical research organizations, as well as pharmaceutical, biotechnology, agrigenomics, and consumer genomics companies.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
500+
Revenue Range
Over 50M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
NASDAQ : ILMN
IP Holdings
250-500

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount Project Title
2006 1 NIH $99,160
Microfluidic capillary assay utilizing holographically *
2006 2 NIH $1,174,372
Representational analysis of DNA copy number/methylation
2006 2 NIH $1,139,664
Development of a Multi-State Decoding Framework
2005 2 NIH $1,381,531
Protease Substrate Array
2005 2 NIH $1,093,804
High-Throughput Methylation Profiling System

Key People / Management

  Jay T Flatley -- President

  Cynthia Allred

  Steven M Barnard

  Todd Dickinson

  Jian-Bing Fan

  Kevin L Gunderson

  Semyon Kruglyak

  Michal Lebl

  John A Moon

  Anupama N Srinivasan

  Chanfeng Zhao